A Study of the Effects of Hepatic Impairment on the Pharmacokinetics and Tolerability of Eliglustat Tartrate

Clinical trial NCT02536911 · COMPLETED

Trial details

NCT number: NCT02536911
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Gaucher Disease

Start date: 2015-09-01
Primary completion: 2016-12-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.